skip to content »

Translational Biology & Molecular Medicine

Houston, Texas

Benchtop, Research, Bedside and Application
Translational Biology & Molecular Medicine Graduate Program
not shown on screen

Susan G. Hilsenbeck, Ph.D.

Susan G. Hilsenbeck

Department of Medicine - Hematology and Oncology
Smith Breast Center

Phone: 713-798-1627
Fax: 713-798-1693


  • Ph.D., Applied Statistics, Departments of Mathematics and Computer Science, Management Science, and Epidemiology and Public Health, University of Miami,
    Miami, FL

Research Interests

  • Design and statistical analysis of translational experiments and clinical trials

Clinical Focus

  • Cancer, especially breast cancer

Selected Publications

  • Pérez-Torres CJ, Massaad CA, Hilsenbeck SG, Serrano F, Pautler RG. In vitro and in vivo magnetic resonance imaging (MRI) detection of GFP through magnetization transfer contrast (MTC). Neuroimage. 2010. 50(2):375-82.
  • Rodriguez AA, Makris A, Wu MF, Rimawi M, Froehlich A, Dave B, Hilsenbeck SG, Chamness GC, Lewis MT, Dobrolecki LE, Jain D, Sahoo S, Osborne CK, Chang JC. DNA repair signature is associated with anthracycline response in triple negative breast cancer patients. Breast Cancer Res Treat. 2010. 123(1):189-96.
  • Medina D, Kittrell F, Hill J, Zhang Y, Hilsenbeck SG, Bissonette R, Brown PH. Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib. Cancer Prev Res (Phila Pa). 2009. 2(2):168-74.
  • Ochsner SA, Steffen DL, Hilsenbeck SG, Chen ES, Watkins C, McKenna NJ. GEMS (Gene Expression MetaSignatures), a Web resource for querying meta-analysis of expression microarray datasets: 17beta-estradiol in MCF-7 cells. Cancer Res. 2009. 69(1):23-6.
  • Speers C, Tsimelzon A, Sexton K, Herrick AM, Gutierrez C, Culhane A, Quackenbush J, Hilsenbeck S, Chang J, Brown P. Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer. Clin Cancer Res. 2009. 15(20):6327-40.
  • Siwko SK, Dong J, Lewis MT, Liu H, Hilsenbeck SG, Li Y. Evidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells–implications for pregnancy-induced protection against breast cancer. Stem Cells. 2008. 26(12):3205-9.
  • Hilsenbeck SG, Osborne CK. Is there a role for adjuvant tamoxifen in progesterone receptor-positive breast cancer? An in silico clinical trial. Clin Cancer Res. 2006. 12(3 Pt 2):1049s-1055s.

E-mail this page to a friend